Zynerba Higher Despite Q3 Miss

0 Comments 3 view(s)

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares are trading higher by $1.07 at $13.18 in Tuesday’s session. Despite a Q3 EPS miss of 4 cents, the stock is trading in the green.

read more